ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED

Active
Company number 16539429Private limited companyIncorporated 2025

Key figures

£1
Net assets 2025

Like most small UK companies, ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025

Sector comparison

SIC 21100

Where the company stands among the 1,055 active companies whose first SIC code is 21100 (Manufacture of basic pharmaceutical products).

Company age1.4 years
Younger than 85% · median 9.0 years

Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant. The line on each bar marks the median.

Summary: ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED

What kind of company is it?

ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED is a private limited company registered with Companies House under company number 16539429. It was incorporated on 24 Jun 2025. Its status is active. The registered office is in Dartford (DA1). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100), wholesale of pharmaceutical goods (46460).

How is the company doing financially?

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files dormant company accounts. Net assets were £1. The company had an average of 0 employees.

How does it compare with similar companies?

Compared with 1,055 active companies whose first SIC code is 21100: It is younger than 85% of them (median age 9.0 years).

Who runs and controls the company?

One person with significant control is registered.

When are its next filings due?

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 3 Jul 2027.

Filed accounts2025
2025
Total assets1
Total liabilities—
Net assets / total equity1
Average number of employees0

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

Manufacture of basic pharmaceutical products

As described in the company's latest filed accounts.

History

3 events
  1. Financial year 2025 endedAccounts: net assets £1, 0 employees
  2. Ennogen Investments Ltd registered as a person with significant control
  3. Company incorporatedPrivate limited company

Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.